{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-03T15:02:41.626626+00:00","company":{"ticker":"MMSI","cik":856982,"company_name":"MERIT MEDICAL SYSTEMS INC"},"pagination":{"limit":100,"returned":5,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","facts":[{"fact_type":"governance_change","fact_key":"0d30484a4f784d701cbe77adea007543eaefe0fb","cik":856982,"ticker":"MMSI","company_name":"MERIT MEDICAL SYSTEMS INC","filed_at":"2026-05-19T20:54:43+00:00","payload":{"change_type":"bylaw_amendment","effective_date":"2026-05-14","item_codes_triggered":["5.03"],"summary_text":"Board adopted Fifth Amended and Restated Bylaws, making various clarifications and updates"},"claim":"MERIT MEDICAL SYSTEMS INC: Board adopted Fifth Amended and Restated Bylaws, making various clarifications and updates (effective 2026-05-14).","evidence_excerpt":"On May 14, 2026, the Board approved and adopted the Fifth Amended and Restated Bylaws of the Company (the “Fifth A&R Bylaws”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000856982-26-000030","anchor_url":"https://secwatch.observer/filing/0000856982-26-000030#claim-0d30484a4f784d701cbe77adea007543eaefe0fb","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/856982/000085698226000030/0000856982-26-000030-index.htm"},{"fact_type":"earnings_release","fact_key":"be0d731748ed10124924a8eb861a0410b1d5ceef","cik":856982,"ticker":"MMSI","company_name":"MERIT MEDICAL SYSTEMS INC","filed_at":"2026-04-30T23:59:59+00:00","payload":{"eps_text":"GAAP EPS $0.68","guidance_signal":"unknown","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"the quarter ended March 31, 2026","report_date":"2026-04-30","result_type":"reported_results","revenue_text":"$381.9 million"},"claim":"MERIT MEDICAL SYSTEMS INC reported the quarter ended March 31, 2026 results: revenue $381.9 million, EPS GAAP EPS $0.68.","evidence_excerpt":"​ ​ ​ ​ ​ ​ FOR IMMEDIATE RELEASE MERIT MEDICAL REPORTS FIRST QUARTER 2026 RESULTS AND UPDATES FULL-YEAR GUIDANCE ​ Financial Highlights† ● Reported revenue of $381.9 million, up 7% ● Constant currency revenue* and constant currency revenue, organic* up 5% and up 3%, respectively o Constant currency revenue, organic* increased 4%, excluding revenue","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000856982-26-000023","anchor_url":"https://secwatch.observer/filing/0000856982-26-000023#claim-be0d731748ed10124924a8eb861a0410b1d5ceef","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/856982/000085698226000023/0000856982-26-000023-index.htm"},{"fact_type":"executive_change","fact_key":"5c934488eb","cik":856982,"ticker":"MMSI","company_name":"MERIT MEDICAL SYSTEMS INC","filed_at":"2024-05-16T23:59:59+00:00","payload":{"action":"resigned","action_category":"role_change","departure_tone":"not_applicable","effective_date":"2024-05-15","interim":false,"role":"President","role_category":"president","successor_name":"Joseph C. Wright","successor_named":true},"claim":"Fred P. Lampropoulos resigned as President at MERIT MEDICAL SYSTEMS INC.","evidence_excerpt":"In connection with Mr. Wright’s appointment, Fred P. Lampropoulos resigned as President of Merit. Mr. Lampropoulos will continue to serve as Merit’s Chief Executive Officer.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000856982-24-000045","anchor_url":"https://secwatch.observer/filing/0000856982-24-000045#claim-5c934488eb","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/856982/000085698224000045/0000856982-24-000045-index.htm"},{"fact_type":"executive_change","fact_key":"77ad07f74f","cik":856982,"ticker":"MMSI","company_name":"MERIT MEDICAL SYSTEMS INC","filed_at":"2024-05-16T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-05-15","interim":false,"role":"President","role_category":"president","successor_name":null,"successor_named":false},"claim":"Joseph C. Wright was appointed as President at MERIT MEDICAL SYSTEMS INC.","evidence_excerpt":"The Board of Directors of Merit Medical Systems, Inc. (“Merit”) appointed Joseph C. Wright as President of Merit, effective as of May 15, 2024.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000856982-24-000045","anchor_url":"https://secwatch.observer/filing/0000856982-24-000045#claim-77ad07f74f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/856982/000085698224000045/0000856982-24-000045-index.htm"},{"fact_type":"earnings_release","fact_key":"503c8c61c49a553165aab0d7870367da47a4ad34","cik":856982,"ticker":"MMSI","company_name":"MERIT MEDICAL SYSTEMS INC","filed_at":"2024-04-30T23:59:59+00:00","payload":{"eps_text":"$0.48","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"first quarter ended March 31, 2024","report_date":"2024-04-30","result_type":"reported_results","revenue_text":"$323.5 million"},"claim":"MERIT MEDICAL SYSTEMS INC reported first quarter ended March 31, 2024 results: revenue $323.5 million, EPS $0.48.","evidence_excerpt":"mike.piccinino@westwicke.com ​ ​ ​ ​ ​ ​ ​ ​ FOR IMMEDIATE RELEASE MERIT MEDICAL REPORTS RESULTS FOR FIRST QUARTER ENDED MARCH 31, 2024 ● Q1 2024 reported revenue of $323.5 million, up 8.7% compared to Q1 2023 ● Q1 2024 constant currency revenue* up 9.3% compared to Q1 2023 ● Q1 2024 constant currency revenue, organic* up 7.0% compared to Q1 2023 ● Q1 2024","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000856982-24-000035","anchor_url":"https://secwatch.observer/filing/0000856982-24-000035#claim-503c8c61c49a553165aab0d7870367da47a4ad34","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/856982/000085698224000035/0000856982-24-000035-index.htm"}]}